# Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers

> **NCT06613139** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 34 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** YHP2305
- **DRUG:** YHR2404

## Key facts

- **NCT ID:** NCT06613139
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-06
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-10-24
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613139, "Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06613139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*